News Daily Coffee Drinking Lowers Prostate Cancer Risk, Study Suggests

News Active Surveillance Safe for Black Men With Low-risk Diagnosis, Study Finds

News Nubeqa Prescribing Information Updated With New Survival Data

News Orgovyx Now Available in US for Advanced Prostate Cancer

News Oral ARV-110 Shows Promise in Heavily Treated mCRPC Patients

News Long-term ADT Found to Raise Risk of Cardiovascular Death

News FDA Approves Orgovyx, Oral ADT for Advanced Prostate Cancer

News Teams Working in Advanced Cancer Win 2020 PCF Challenge Awards

News Study Describes New Way to Place CRISPR/Cas9 Into Cancer Cells

News Canada Approves Lynparza for Metastatic CRPC Patients With Certain Gene Mutations

News FDA Puts RV001 on Fast Track for Treating Prostate Cancer

News FDA Approves First PSMA-targeted PET Imaging Agent for Prostate Cancer

News FDA Approves FoundationOne Liquid CDx as Companion Test for Lynparza in mCRPC Patients

News, syndicated New $100M Program Aims to Improve Diversity in Clinical Trials

News PCF Helps Fund 2 Centers of Excellence to Treat Veterans With Prostate Cancer

News Puerto Rico to Test miR’s ‘Liquid Biopsy’ in Detecting Prostate Cancers

News AI-enabled Software To Detect Prostate Cancer Bone Metastases Clears FDA

News UK Study to Assess Causes of Greater Prostate Cancer Risk Among Black Men

News European Commission OKs Lynparza for Metastatic CRPC With BRCA Mutations

News Hold Lifted on Phase 1 Trial Testing P-PSMA-101 CAR T-cell Therapy in mCRPC

News CAR T-Cell Therapy, MB-105, Shows Promise in Metastatic CRPC Patient in Phase 1 Trial

News FDA Clears Ezra Prostate AI, a First for Cancer Imaging

News New Targeted Therapy Trial Opens, Part of PC-BETS Metastatic CRPC Study

News ADT Not Needed With Radiation in Favorable Intermediate-Risk PC

News Provenge Improves Survival in mCRPC Patients Over Xtandi, Zytiga, Real-world Study Finds

News Trial to Test Focal Laser Ablation Therapy for Localized Prostate Cancer

News New AI Algorithm Can Accurately Identify, Grade Prostate Cancer

News Veru Completes Enrollment for Second Part of Phase 1/2 VERU-111 Trial

News Lantheus Seeks FDA Approval of PyL Prostate Cancer Imaging Agent

News Relugolix Fails to Delay Castration Resistance in Advanced PC, Trial Shows

News Most nmCRPC Patients Can Safely Take Full Dose of Nubeqa, Trial Analysis Shows

News Phase 1 Trial of Oral Treatment for Metastatic CRPC Doses First Patient

News Lynparza’s Approval Favored in EU for mCRPC Patients with BRCA Mutations

News NCI Grant to Probe Link Between Prostate Cancer and Fatty Cells in Bone Marrow

News NIH Grants Dartmouth Team $2.5M to Develop Device for Detecting Cancer Cells

News IPCR Launches Exercise Video Series for Prostate Cancer Patients

News ‘Eat It to Beat It’ Challenge to Honor Prostate Cancer Awareness Month

News FDA Approves Blood Test That Can Identify Cancers Eligible for Targeted Therapies

News Tolmar Affirms Full Supply of Eligard for Palliative Treatment of Prostate Cancer

News Google AI System Outperforms General Pathologists in Grading Prostate Cancers, Study Finds

News Dosing Begins in Trial of PET Imaging Agent to Detect Prostate Cancer’s Return

News Cryotherapy May Ably Treat Intermediate-risk Prostate Cancer

News Collaboration Seeks to Reduce Prostate Cancer Disparities in African Americans

News New Guidelines for Care of Advanced Prostate Cancer Released

News New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy

News First AI-based Cancer Detection Application Slated for UK Rollout

News Laser Focal Therapy Effective, Causes Few Side Effects, 10-Year Trial Data Shows

News University of Colorado Launches PreView Medical for PC Diagnosis, Treatment

News Vaccine Shows Promise in Advanced Prostate Cancer, Proof-of-Concept Study Shows

News, syndicated FDA’s New ‘Project Patient Voice’ to Share Symptoms Data From Cancer Trials

News Ipatasertib Combo Fares Well in Early Results of IPATential150 Phase 3 Study

News Relugolix Granted FDA Priority Review as New Treatment Type

News Recommendation Against PSA Routine Screening May Have Contributed to Higher Rates of Advanced PC

News Veyonda Aids Radiation Therapy in Reaching Distant Lesions in Late-stage Cancer Trial

News Cancer DNA Levels in Blood Can Predict Treatment Responses

News Xtandi Plus ADT Bolsters Survival in High-risk Patients, Phase 3 Trial Finds

News U.K. Study to Examine Genetic Screening for Large Prostate Cancer Population

News NHS England Offers Xtandi, Zytiga to New PC Patients During COVID-19 Pandemic

News ADT May Protect Prostate Cancer Patients from COVID-19, Study Suggests

News Updated Guidelines Recommend Rubraca for Some Prostate Cancer Patients

News Rubraca Receives Conditional FDA Approval for metastatic CRPC Patients with BRCA Mutations

News FDA Approves Lynparza for mCRPC Patients with Mutations in DNA Repair Genes

News Erleada Add-on Significantly Extends Survival in Non-metastatic CRPC, SPARTAN Analysis Shows

News Yervoy Can Benefit Certain mCRPC Patients with Few Mutations in Tumors, Trial Finds

News, syndicated Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

News FDA Asked to Approve Relugolix to Treat Advanced Prostate Cancer

News Cancer Vaccine Plus Opdivo Showing Promise in Advanced Prostate Cancer Trial

News Gene Variant Seen to Promote Castration-resistant Disease in Whites

News Winners Named for Prostate Cancer Foundation’s TRUE Love Awareness Contest

News Guidelines for Radiation Therapy with COVID-19 Urge Less Treatment

News Combining Two Biopsy Methods Improves PC Diagnosis, Study Shows

News Urine Biomarkers Can Be Used to Develop Test for Prostate Cancer, Study Finds

News Proscia and UCSF Partnering to Deliver AI Apps to Improve Cancer Diagnosis

News Veru Advances Prostate Cancer Therapy VERU-111 to Phase 2 Portion of Trial

News Adoptive Cell Therapy Can Slow Prostate Cancer Growth, Study in Mice Reports

News Ciforadenant Has Promising Anti-tumor Activity in mCRPC, Early Data Show

News Prolaris Test Predicts Which PC Patients Benefit from Combo Therapy, Study Finds

News 3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows

News Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

News Genetic Test Seen to Predict Patients Helped by ADT Use After Surgery

News Statins, Metformin May Extend Survival in High-risk Prostate Cancer, Large Study Suggests

News Decipher GRID ‘Signature’ Predicts Chemo Benefits in HSPC, Research Shows

News High Vegetable Diet Does Not Halt Prostate Cancer, Study Finds

News Cabometyx-Tecentriq Combo Leads to Lasting Response in Men with Advanced PC, Phase 1b Trial Data Shows

News Adding Provenge to Xtandi, Zytiga Reduces Risk of Death by 45% in mCRPC Patients, Data Shows

News Onvansertib’s Addition Aids Responses to Zytiga Even in Resistant Patients, New Trial Data Show

News eRapa Leads to Boost in Immune Cells in Low-Grade Prostate Cancer Patients, Phase 1b Data Suggest

News UPenn Researchers Awarded $500K Grant to Develop CAR T-cell Therapy for Advanced PC

News Xtandi Significantly Improves Overall Survival in Men with High-risk CRPC, Phase 3 Final Data Show

News Concerto, Pfizer Expand Data Partnership to Include Prostate, Other Cancers

News Stony Brook Team Given $4.2M Grant to Expand Promising Work in Advanced Prostate Cancer

News Erleada Approved in Europe to Treat Metastatic Hormone-sensitive Prostate Cancer

News First Patient Dosed in Early Trial Testing ORIC-101, Xtandi Combo for Metastatic Prostate Cancer

News DNA Non-coding Regions Identified as Therapeutic Targets for Prostate Cancer, New Study Suggests

News Exelixis to Expand Group of mCRPC Patients in Phase 1b Trial Testing Cabometyx-Tecentriq Combo

News FDA OKs Phase 2b Trial on SUBA-Itraconazole for Metastatic Castration-resistant Prostate Cancer

News FDA Grants Priority Review to Lynparza as Treatment for Mutated Metastatic Castration-resistant Prostate Cancer

News Zuclomiphene Safely Eases Hot Flashes Linked to ADT Use, Phase 2 Trial Reports

News Rubraca Granted FDA Priority Review for Advanced Prostate Cancer with BRCA Mutations

News Advaxis Seeks FDA Approval to Begin Phase 1 Trial of its ADXS-504 Immunotherapy for Prostate Cancer